Viewing Study NCT00964158


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2025-12-25 @ 10:05 PM
Study NCT ID: NCT00964158
Status: COMPLETED
Last Update Posted: 2018-02-19
First Post: 2009-08-20
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-09-10
Start Date Type: None
Primary Completion Date: 2010-11-27
Primary Completion Date Type: ACTUAL
Completion Date: 2010-11-27
Completion Date Type: ACTUAL
First Submit Date: 2009-08-20
First Submit QC Date: None
Study First Post Date: 2009-08-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-07-31
Results First Submit QC Date: None
Results First Post Date: 2018-02-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2010-12-16
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2017-07-31
Last Update Post Date: 2018-02-19
Last Update Post Date Type: ACTUAL